
News from go2.org
We’ve assigned a rating of Unknown factuality to go2.org. You can read more about how we’ve determined go2.org’s credibility and reliability as a news source here: https://groundnews.lakegeneva.lib.wi.us/rating-system.
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top go2.org News

Pharma · United States(MedPage Today) -- The FDA approved taletrectinib (Ibtrozi) -- a next-generation oral ROS1 tyrosine kinase inhibitor (TKI) -- for the treatment of adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC)...See the Story
Next-Generation TKI Approved for Advanced ROS1-Positive Lung Cancer
100% Center coverage: 2 sources

Cancer · United StatesWe are deeply concerned that the President’s Fiscal Year 2026 (FY26) budget does not reflect the public’s call for sustained and robust investments in cancer research. Instead, it threatens to reverse decades of progress. On Friday, May 30, 2025, the Department of Health and Human Services (HHS) released its Fiscal Year 2026 Budget in Brief, which proposes drastic cuts to key federal health agencies, including the National Institutes of Health (…Read Article
As Time Is Ticking, Our Government Could Be Returning to Funding Levels from Decades Ago! - GO2 for Lung Cancer
A Family’s Tribute Turns into a Powerful Fundraiser - GO2 for Lung Cancer
From Doctor to Patient: Dr. Lin's Story - GO2 for Lung Cancer
Strengthening State Plans to Fight Lung Cancer: A Roadmap for Action - GO2 for Lung Cancer
Lung Cancer and Women: A Q&A with Narjust Florez, MD - GO2 for Lung Cancer
Margaret Richardson and Karen Mostes-Withrow Join GO2 for Lung Cancer Board of Directors
FDA OKs New Drug for Lung Cancer With c-Met Overexpression
100% Center coverage: 1 sources
Trump’s budget proposes steep cuts to NIH, health funding
63% Center coverage: 152 sources